|
Robert Taub has served as our president chief executive officer and a member of our board of directors since the founding of OMRIX in 1995. Prior to establishing OMRIX Mr. Taub was the cofounder of Octapharma A.G. a Swiss plasma fractionation and pharmaceutical company which successfully introduced innovative plasma derivative products to the market. During his time at Octapharma from 1983 to 1995 the company underwent a successful transformation from a start-up operation to an integrated manufacturing enterprise. He also founded a research and development group in Israel and initiated and directed the management of a biological fibrin sealant development project. Prior to Octapharma Mr. Taub held various general management and sales and marketing positions with Armour Pharmaceutical Revlon Health Care Group Baxter Travenol Laboratories Inc. now Baxter International Inc. and Monsanto Company. He has a B.A. in languages from the University of Antwerp and an M.B.A. from INSEAD (the European Institute of Business Administration) in Fontainebleau France. | 